NOVEL INHIBITORS OF CHOLESTERYL ESTER TRANSFER PROTEIN

被引:14
|
作者
CHACKALAMANNIL, S
XIA, Y
WANG, YG
TSAI, HG
CZARNIECKI, M
WANG, S
CLEMMONS, A
AHN, HS
BOYKOW, G
机构
[1] Schering-Plough Research Institute, Kenilworth, NJ 07033
关键词
D O I
10.1016/0960-894X(95)00342-Q
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The synthesis and CETP inhibitory activity of a series of compounds related to wiedendiols (1a,1b) are reported. It is proposed that a two point pharmacophore consisting of a catechol group and a large hydrophobic anchor is necessary for activity.
引用
收藏
页码:2005 / 2010
页数:6
相关论文
共 50 条
  • [31] ASSAY OF CHOLESTERYL ESTER TRANSFER ACTIVITY AND PURIFICATION OF A CHOLESTERYL ESTER TRANSFER PROTEIN
    OGAWA, Y
    FIELDING, CJ
    [J]. METHODS IN ENZYMOLOGY, 1985, 111 : 274 - 285
  • [32] MECHANISM OF CHOLESTERYL ESTER TRANSFER MEDIATED BY PLASMA CHOLESTERYL ESTER TRANSFER PROTEIN
    SWENSON, TL
    BROCIA, RW
    TALL, A
    [J]. ARTERIOSCLEROSIS, 1987, 7 (05): : A537 - A537
  • [33] Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors
    Chapman, M. John
    Le Goff, Wilfried
    Guerin, Maryse
    Kontush, Anatol
    [J]. EUROPEAN HEART JOURNAL, 2010, 31 (02) : 149 - 164
  • [34] Diphenylpyridylethanamine (DPPE)-based aminoheterocycles as cholesteryl ester transfer protein inhibitors
    Wang, Yufeng
    Yang, Wu
    Finlay, Heather J.
    Harikrishnan, Lalgudi S.
    Jiang, Ji
    Kamau, Muthoni G.
    Van Kirk, Katy
    Nirschl, David S.
    Taylor, David S.
    Chen, Alice Ye A.
    Yin, Xiaohong
    Sleph, Paul G.
    Yang, Richard Z.
    Huang, Christine S.
    Adam, Leonard P.
    Lawrence, R. Michael
    Wexler, Ruth R.
    Salvati, Mark E.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (03) : 860 - 864
  • [35] Mechanism of Inhibition of Cholesteryl Ester Transfer Protein by Small Molecule Inhibitors
    Chirasani, Venkat R.
    Sankar, Revathi
    Senapati, Sanjib
    [J]. JOURNAL OF PHYSICAL CHEMISTRY B, 2016, 120 (33): : 8254 - 8263
  • [36] Future of Cholesteryl Ester Transfer Protein (CETP) Inhibitors: A Pharmacological Perspective
    Mohammadpour, Amir Hooshang
    Akhlaghi, Fatemeh
    [J]. CLINICAL PHARMACOKINETICS, 2013, 52 (08) : 615 - 626
  • [37] Therapy with cholesteryl ester transfer protein (CETP) inhibitors and diabetes risk
    Masson, W.
    Lobo, M.
    Siniawski, D.
    Huerin, M.
    Molinero, G.
    Valero, R.
    Nogueira, J. P.
    [J]. DIABETES & METABOLISM, 2018, 44 (06) : 508 - 513
  • [38] Diphenylpyridylethanamine (DPPE) Derivatives as Cholesteryl Ester Transfer Protein (CETP) Inhibitors
    Harikrishnan, Lalgudi S.
    Finlay, Heather J.
    Qiao, Jennifer X.
    Kamau, Muthoni G.
    Jiang, Ji
    Wang, Tammy C.
    Li, James
    Cooper, Christopher B.
    Poss, Michael A.
    Adam, Leonard P.
    Taylor, David S.
    Chen, Alice Ye A.
    Yin, Xiaohong
    Sleph, Paul G.
    Yang, Richard Z.
    Sitkoff, Doree F.
    Galella, Michael A.
    Nirschl, David S.
    Van Kirk, Katy
    Miller, Arthur V.
    Huang, Christine S.
    Chang, Ming
    Chen, Xue-Qing
    Salvati, Mark E.
    Wexler, Ruth R.
    Lawrence, R. Michael
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (13) : 6162 - 6175
  • [39] Cholesteryl Ester Transfer Protein (CETP) Inhibitors: Is There Life After Torcetrapib?
    Neeli, Hemanth
    Rader, Daniel J.
    [J]. CARDIOLOGY CLINICS, 2008, 26 (04) : 537 - +
  • [40] CHOLESTERYL ESTER TRANSFER PROTEIN (CETP) INHIBITORS AND THEIR ROLE IN CARDIOVASCULAR DISORDERS
    Kontush, A.
    [J]. DRUGS OF THE FUTURE, 2011, 36 (05) : 377 - 384